Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-vivo Study of the Efficacy of Hyperimmune Bovine Colostrum to Block Absorption of Gliadin Peptides in the Human Intestine: a Novel Potential Intervention for Celiac Disease and Non-celiac Gluten Sensitivity

NCT05555446 is registered in ClinicalTrials.gov with Milky Way Life Sciences LLC as lead sponsor.

NCT NCT05555446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05555446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-vivo Study of the Efficacy of Hyperimmune Bovine Colostrum to Block Absorption of Gliadin Peptides in the Human Intestine: a Novel Potential Intervention for Celiac Disease and Non-celiac Gluten Sensitivity
Lead sponsor
Milky Way Life Sciences LLC
Phase
Phase 1
Overall status
Suspended
Start date
September 22, 2022
Completion date
January 1, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, gluten sensitivity, non-celiac gluten sensitivity